The ASAM Principles of Addiction Medicine 5th Edition

SECTION 1. Basic Science and Core Concepts

Chapter 1. Drug Addiction: The Neurobiology of Behavior Gone Awry

Chapter 2. The Epidemiology of Substance Use Disorders

Chapter 3. The Anatomy of Addiction

Chapter 4. From Neurobiology to Treatment: Progress Against Addiction

Chapter 5. Understanding “Behavioral Addictions”: Insights from Research

SECTION 2. Pharmacology

Chapter 6. Pharmacokinetic and Pharmacodynamic Principles

Chapter 7. The Pharmacology of Alcohol

Chapter 8. The Pharmacology of Nonalcohol Sedative Hypnotics

Chapter 9. The Pharmacology of Opioids

Chapter 10. The Pharmacology of Cocaine, Amphetamines, and Other Stimulants

Chapter 11. The Pharmacology of Caffeine

Chapter 12. The Pharmacology of Nicotine and Tobacco

Chapter 13. The Pharmacology of Marijuana

Chapter 14. The Pharmacology of Hallucinogens

Chapter 15. The Pharmacology of Dissociatives

Chapter 16. The Pharmacology of Inhalants

Chapter 17. The Pharmacology of Anabolic-Androgenic Steroids

SECTION 3. Diagnosis, Assessment, and Early Intervention

Chapter 18. Screening and Brief Intervention

Chapter 19. Laboratory Diagnosis

Chapter 20. Assessment

Chapter 21. Environmental Approaches to Prevention: A Community-Based Perspective

SECTION 4. Overview of Addiction Treatment

Chapter 22. Addiction Medicine in America: Its Birth and Early History (1750-1935) with a Modern Postscript

Chapter 23. Treatment of Heavy Drinking and Alcohol Use Disorder

Chapter 24. The Treatment of Drug Addiction: An Overview

Chapter 25. Moving Toward Integrated Care for Substance Use Disorders: Lessons from History and the Rest of Health Care

Chapter 26. Effects of Treatment Setting, Duration, and Amount on Patient Outcomes

Chapter 27. The ASAM Criteria and Matching Patients to Treatment

Chapter 28. Linking Addiction Treatment with Other Medical and Psychiatric Treatment Systems

Chapter 29. Alternative Therapies for Alcohol and Drug Addiction

Chapter 30. The Harm Reduction Approach to Prevention and Treatment

Chapter 31. Quality Improvement for Addiction Treatment

Chapter 32. Nursing Roles in Addressing Addiction

Chapter 33. International Perspectives on Addiction Management

SECTION 5. Special Issues in Addiction

Chapter 34. Nonmedical Use, Misuse, and Abuse of Prescription Medications

Chapter 35. Special Issues in Treatment: Women

Chapter 36. Treatment of Older Adults

Chapter 37. Cultural Issues in Addiction Medicine

Chapter 38. College Student Drinking

Chapter 39. Pathologic Gambling: Clinical Characteristics and Treatment

Chapter 40. Sexual Addiction

Chapter 41. Physician Health Programs and Addiction among Physicians

SECTION 6. Management of Intoxication and Withdrawal

Chapter 42. Management of Intoxication and Withdrawal: General Principles

Chapter 43. Management of Alcohol Intoxication and Withdrawal

Chapter 44. Management of Sedative-Hypnotic Intoxication and Withdrawal

Chapter 45. Management of Opioid Intoxication and Withdrawal

Chapter 46. Management of Stimulant, Hallucinogen, Marijuana, Phencyclidine, and Club Drug Intoxication and Withdrawal

SECTION 7. Pharmacologic Interventions

Chapter 47. Medications for Use in Alcohol Rehabilitation

Chapter 48. Pharmacologic Intervention for Sedative-Hypnotic Addiction

Chapter 49. Pharmacologic Interventions for Opioid Dependence

Chapter 50. Opioid Maintenance Treatment

Chapter 51. Special Issues in Office-Based Opioid Treatment

Chapter 52. Pharmacologic Interventions for Cocaine, Methamphetamine, and Other Stimulant Addiction

Chapter 53. Pharmacologic Interventions for Tobacco Dependence

Chapter 54. Pharmacologic Interventions for Other Drug and Multiple Drug Addictions

SECTION 8. Behavioral Interventions

Chapter 55. Enhancing Motivation to Change

Chapter 56. Group Therapies

Chapter 57. Individual Treatment

Chapter 58. Contingency Management and the Community Reinforcement Approach

Chapter 59. Behavioral Interventions in Smoking Cessation

Chapter 60. Network Therapy

Chapter 61. Therapeutic Communities

Chapter 62. Aversion Therapies

Chapter 63. Family Involvement in Addiction, Treatment, and Recovery

Chapter 64. Twelve-Step Facilitation Approaches

Chapter 65. Microprocessor Abuse and Internet Addiction

Chapter 66. Relapse Prevention: Clinical Models and Intervention Strategies

Chapter 67. Medical Management Techniques and Collaborative Care: Integrating Behavioral with Pharmacologic Interventions in Addiction Treatment

Chapter 68. Conceptual and Treatment Issues in “Behavioral Addictions”

SECTION 9. Mutual Help, Twelve Step, and Other Recovery Programs

Chapter 69. Twelve-Step Programs in Addiction Recovery

Chapter 70. Recent Research into Twelve-Step Programs

Chapter 71. Spirituality in the Recovery Process

SECTION 10. Medical Disorders and Complications of Addiction

Chapter 72. Medical and Surgical Complications of Addiction

Chapter 73. Cardiovascular Consequences of Alcohol and Other Drug Use

Chapter 74. Liver Disorders Related to Alcohol and Other Drug Use

Chapter 75. Renal and Metabolic Disorders Related to Alcohol and Other Drug Use

Chapter 76. Gastrointestinal Disorders Related to Alcohol and Other Drug Use

Chapter 77. Respiratory Tract Disorders Related to Alcohol and Other Drug Use

Chapter 78. Neurologic Disorders Related to Alcohol and Other Drug Use

Chapter 79. Human Immunodeficiency Virus, Tuberculosis, and Other Infectious Diseases Related to Alcohol and Other Drug Use

Chapter 80. Sleep Disorders Related to Alcohol and Other Drug Use

Chapter 81. Traumatic Injuries Related to Alcohol and Other Drug Use: Epidemiology, Screening, and Prevention

Chapter 82. Endocrine and Reproductive Disorders Related to Alcohol and Other Drug Use

Chapter 83. Alcohol and Other Drug Use during Pregnancy: Management of the Mother and Child

Chapter 84. Surgical Interventions in the Alcohol- or Drug-Using Patient

SECTION 11. Co-Occurring Addiction and Psychiatric Disorders

Chapter 85. Substance-Induced Mental Disorders

Chapter 86. Co-Occurring Addictive and Mood Disorders

Chapter 87. Co-Occurring Addiction and Anxiety Disorders

Chapter 88. Co-Occurring Addiction and Psychotic Disorders

Chapter 89. Co-Occurring Addictive Disorder and Attention Deficit Hyperactivity Disorder

Chapter 90. Co-Occurring Personality Disorders and Addiction

Chapter 91. Posttraumatic Stress Disorder and Substance Use Disorder Comorbidity

Chapter 92. Co-Occurring Addiction and Eating Disorders

SECTION 12. Pain and Addiction

Chapter 93. The Pathophysiology of Chronic Pain and Clinical Interfaces with Addiction

Chapter 94. Psychological Issues in the Management of Pain

Chapter 95. Rehabilitation Approaches to Pain Management

Chapter 96. Nonopioid Pharmacotherapy of Pain

Chapter 97. Opioid Therapy of Pain

Chapter 98. Comorbid Pain and Addiction

Chapter 99. Legal and Regulatory Considerations in Opioid Prescribing

SECTION 13. Children and Adolescents

Chapter 100. Epidemiology of Adolescent Substance Use

Chapter 101. Preventing Substance Use among Children and Adolescents

Chapter 102. Neurobiology of Addiction from a Developmental Perspective

Chapter 103. Screening and Brief Intervention for Adolescents

Chapter 104. Assessing Adolescent Substance Use

Chapter 105. Placement Criteria and Strategies for Adolescent Treatment Matching

Chapter 106. Adolescent Treatment and Relapse Prevention

Chapter 107. Pharmacotherapy for Adolescents with Substance Use Disorders

Chapter 108. Co-Occurring Psychiatric Disorders in Adolescents

SECTION 14. Ethical, Legal, and Liability Issues in Addiction Practice

Chapter 109. Ethical Issues in Addiction Practice

Chapter 110. Consent and Confidentiality Issues in Addiction Practice

Chapter 111. Clinical, Ethical, and Legal Considerations in Prescribing Drugs with Abuse Potential

Chapter 112. The Science and Clinical Uses of Drug Testing

Chapter 113. Drug Treatment Courts and the Treatment of Persons in the Criminal Justice System

Chapter 114. Preventing and Treating Substance Use Disorders in Military Personnel

Chapter Contributors